Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GYRE · against 1,216 other Healthcare companies
Ranked #993 of 1,217 · scores higher than 18% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 10–19, including GYRE · Click a bar to see the companies
Mainly because of its earnings per share growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | GYRE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -3.4% | 6.1% | 23% | 33% | |
| Earnings per share growthHigher is better · 682 reported | -60.0% | 9.7% | 9% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 4.5% | 5.8% | 43% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 993 | 2.1B CNY (≈$295M) | 18 | 39 | |
| 993 | 1.4B MYR (≈$309M) | 18 | 31 | |
| 993 | 222M GBP (≈$288M) | 18 | 13 | |
| 993 | 21.8B USD | 18 | 32 | |
| 993 | 471M USD | 18 | 21 | |
| 993 | 474M USD | 18 | 46 | |
| 993 | 471M NZD (≈$282M) | 18 | 23 | |
| 993 | 1.5B USD | 18 | 30 | |
| 993 | 528M USD | 18 | 58 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score